Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

POLYMYXIN B FOR INJECTION USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of POLYMYXIN B FOR INJECTION USP in Canada?

Yes. POLYMYXIN B FOR INJECTION USP 50MG has an active shortage reported to Health Canada (last updated October 5, 2017).

When will POLYMYXIN B FOR INJECTION USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Affected strength50MG
Report last updated2017-10-05
Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02375893

Strength

50MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAMUSCULAR INTRATHECAL INTRAVENOUS OPHTHALMIC

Active Ingredient

POLYMYXIN B

See all POLYMYXIN B products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History